Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Bouscas Med is a venture capital and angel investment firm specializing in the life sciences and healthcare sectors. Founded in 2002 by Alexis de Longevialle, the firm operates as a strategic partner and "company builder," providing early-stage and growth capital to innovative medical technology and biotechnology companies. Bouscas Med is most notably recognized for its long-term support of Carthera, a clinical-stage medtech company developing ultrasound-based devices for brain disorders, having participated in multiple funding rounds since 2010. The firm also holds investments in digital health and telemedicine ventures such as Teo (Healthcare Technology Systems). Based in Belgium, Bouscas Med focuses on disruptive innovations that address significant unmet medical needs in neurology and oncology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BOUSCAS.